IXICO plc (IXI.L): Half-year report | RenalytixAI (RENX.L): Joint Venture with Mount Sinai to develop a Covid-19 antibody test
20 May 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
IXICO Plc (IXI:LON), 8.8 | Renalytix Plc (RENX:LON), 27.5
- Published:
20 May 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
IXICO plc (IXI.L): Half-year report | RenalytixAI (RENX.L): Joint Venture with Mount Sinai to develop a Covid-19 antibody test